¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lateral spinal sclerosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • systemic sclerosis
    Àü½Å°æÈ­Áõ
  • sclerosis
    1. °æÈ­, ±»À½ 2. °æÈ­Áõ, ±»À½Áõ
  • sclerosis mammae
    À¯¹æ°æÈ­Áõ
  • vascular sclerosis
    µ¿¸Æ°æÈ­Áõ
  • central lateral nucleus
    °¡ÂÊÁß½ÉÇÙ, Á߽ɿÜÃøÇÙ
  • lateral
    °¡ÂÊ-, ¿ÜÃø-
  • lateral antebrachial cutaneous nerve
    °¡ÂʾƷ¡ÆÈÇǺνŰæ, ¿ÜÃøÀü¿ÏÇǽŰæ
  • lateral brachial cutaneous nerve
    °¡ÂÊÀ§ÆÈÇǺνŰæ, ¿ÜÃø»ó¿ÏÇǽŰæ
  • lateral canthus
    °¡ÂÊ´«±¸¼®, ¿Ü¾È°¢
  • lateral cerebral fossa
    ´ë³ú°¡ÂÊ¿À¸ñ, ´ë³úÃø¿Í
  • lateral chain
    °ç»ç½½
  • lateral conjugate paralysis
    °¡ÂÊÁֽø¶ºñ, ¿ÜÃøÁֽø¶ºñ
  • lateral corporal fold
    ¸öÅë°¡ÂÊÁÖ¸§
  • lateral corticospinal tract
    °¡ÂʰÑÁúô¼ö·Î, ¿ÜÃøÇÇÁúô¼ö·Î
  • lateral decubitus
    ¿·´©¿ò, Ãø¿ÍÀ§, ¿·´©¿îÀÚ¼¼
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sclerosis
    °æÈ­(Áõ), ±»À½(Áõ)
  • sclerosis mammae
    À¯¹æ°æÈ­Áõ
  • systemic sclerosis
    (¢¡systemic scleroderma) Àü½ÅÇǺΰæÈ­Áõ
  • tuberous sclerosis
    °áÀý°æÈ­Áõ
  • tubular sclerosis
    ¼¼°ü°æÈ­Áõ
  • vascular sclerosis
    (¢¡arteriosclerosis) µ¿¸Æ°æÈ­Áõ
  • lateral sacral artery
    °¡ÂʾûÄ¡µ¿¸Æ
  • lateral gastrocnemius bursa
    °¡ÂÊÀåµýÁö±ÙÁÖ¸Ó´Ï
  • lateral maxillary buttress
    °¡ÂÊÀ§ÅλÀ¹öÆÀº®
  • central lateral nucleus
    °¡ÂÊÁß½ÉÇÙ
  • lateral canthus
    °¡ÂÊ´«±¸¼®
  • lateral chain
    (¢¡side chain) °ç»ç½½
  • lateral nasal cartilage
    °¡ÂÊÄÚ¿¬°ñ
  • lateral decubitus
    ¿·´©¿ò, Ãø¿ÍÀ§, ¿·´©¿îÀÚ¼¼
  • lateral cerebral fossa
    ´ë³ú°¡ÂÊ¿À¸ñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • posterior lateral nasal arteries
    °¡ÂʵÚÄÚµ¿¸Æ
  • prominence of lateral semicircular canal
    °¡ÂÊ¹Ý°í¸®°üÀ¶±â
  • prominence of lateral semicircular canal ³ª prominentia canalis semicircularis lateralis
    ¿ÜÃø¹Ý°í¸®°ñ°üÀ¶±â, ¿ÜÃø¹Ý±Ô°üÀ¶±â(èâö°ÚâЮηëØÑÃ).
  • prominence of lateral semicircular canal ³ª prominentia canalis semicircularis lateralis
    ¿ÜÃø¹Ý°í¸®°ñ°üÀ¶±â, ¿ÜÃø¹Ý±Ô°üÀ¶±â(èâö°ÚâЮηëØÑÃ).
  • pterygoid muscle lateral
    ¿ÜÃø³¯°³±Ù, ¿ÜÀ͵¹±Ù(èâìÏÔÍÐÉ).
  • Bournevilles disease->tuberous sclerosis
    ºÎ¸£³×ºôº´
  • SSP= spasmodic spinal paralysis
    °­Á÷¼º ô¼ö¸¶ºñ.
  • annular sclerosis
    À±»ó°æÈ­Áõ(¡­Ìãûùñø).
  • anterior spinal artery
    ¾Õô¼öµ¿¸Æ
  • anterior spinal artery syndrome
    Àüô¼öµ¿¸ÆÁõÈıº(¡­ñøý¦ÏØ).
  • anterior spinal syndrome
    Àü»èÁõÈıº(¡­ñøý¦ÏØ).
  • anterior spinal veins
    ¾Õô¼öÁ¤¸Æ
  • aortic sclerosis
    ´ëµ¿¸Æ°æÈ­(Áõ)(¡­Ìãûùñø).
  • arachnoid of spinal cord
    ô¼ö°Å¹Ì¸·
  • areolar choroidal sclerosis
    ¿øÇü¸Æ¶ô¸·°æÈ­(Áõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diffuse cerebral sclerosis
    ¹Ì¸¸¼º ³ú°æÈ­Áõ.
  • diffuse sclerosis
    ¹ü¹ß¼º °æÈ­Áõ(ÛñÛ¡àõÌãûùñø).
  • diffuse systemic sclerosis
    ±¤¹üÀ§ Àü½Å °æÈ­Áõ
  • disseminated sclerosis
    ÆÄÁ¾¼º °æÈ­Áõ(¡­Ìãûùñø).
  • endocardial sclerosis
    ½É³»¸·°æÈ­Áõ(¡­Ìãûùñø).
  • funicular sclerosis
    »è»ó°æÈ­(Áõ).
  • hepatoportal sclerosis
    °£¹®¸Æ°æÈ­Áõ.
  • hereditary cerebellar sclerosis
    À¯Àü¼º ¼Ò³ú°æÈ­Áõ.
  • hodgkins disease,nodular sclerosis
    °áÀý¼º °æÈ­¼º
  • insular sclerosis
    µµ°æÈ­Áõ(ÓöÌãûùñø).
  • lobar sclerosis
    ¿±°æÈ­Áõ(ç¨Ìãûùñø).
  • medial calcific sclerosis
    Á߸·¼®È¸È­¼º °æÈ­Áõ(ñ騝à´üéûùàõ ¡­)
  • multiple cerebral sclerosis
    ¹æ»ç ´Ù¹ß¼º ´ë³ú°æÈ­Áõ(ÒýÛ¡àõÓÞÒàÌãûùñø).
  • multiple cerebral sclerosis
    ´Ù¹ß¼º ´ë³ú°æÈ­Áõ(Û¯ÞÒ¡­ÓÞÒàÌãûùñø)
  • multiple sclerosis
    ¹æ»ç ÀçȰ´Ù¹ß¼º °æÈ­Áõ(ÒýÛ¡àõÌãûùñø).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Sections of spinal cord
    ô¼öÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ô¼öÀÇ ´Ü¸é
  • Spinal veins
    ô¼öÁ¤¸Æ
    [¿¾ ¿ë¾î] ô¼öÁ¤¸Æ
  • Primordium of spinal extensor muscles
    ôÁÖÆï±Ù¿ø±â
    [¿¾ ¿ë¾î] ôÃ߽űٿø±â
  • Spinal myotome
    ôÃß±ÙÀ°ºÐÀý
    [¿¾ ¿ë¾î] ôÃß±ÙÀý
  • Lateral corticospinal tract [Lateral pyramidal tract]
    °¡ÂʰÑÁúô¼ö·Î [°¡ÂÊÇǶó¹Ô·Î]
    [¿¾ ¿ë¾î] ¿ÜÃøÇÇÁúô¼ö·Î(ÃßÃ¼Ãø»è·Î)
  • Lateral atrial vein of lateral ventricle
    °¡Âʳú½Ç°¡Âʺ®Á¤¸Æ
    [¿¾ ¿ë¾î] Ãø³ú½Ç¿ÜÃøº®Á¤¸Æ
  • Lateral frontobasal artery [Lateral orbitofrontalis branch]
    °¡ÂÊÀ̸¶¹Ù´Úµ¿¸Æ [°¡ÂÊ´«È®À̸¶¿±°¡Áö]
    [¿¾ ¿ë¾î] ¿ÜÃøÀüµÎÀúµ¿¸Æ
  • (Lateral costal branch)
    (°¡Âʰ¥ºñ°¡Áö)
    [¿¾ ¿ë¾î] ¿ÜÃø´Á°ñÁö
  • (Lateral lacunar node)
    (°¡ÂÊÇ÷°üÄ­¸²ÇÁÀý)
    [¿¾ ¿ë¾î] ¿ÜÃø¿ä¿ÍÀÓÆÄÀý
  • Lateral
    °¡ÂÊ [¿ÜÃø]
    [¿¾ ¿ë¾î] ¿ÜÃø
  • Lateral cutaneous branch (of thorax)
    °¡ÂÊ(°¡½¿)ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ¿ÜÃø(Èä)ÇÇÁö
  • Lateral cuteneous branch (of abdomen)
    °¡ÂÊ(¹è)ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ¿ÜÃø(º¹)ÇÇÁö
  • Lateral pectoral nerve
    °¡Âʰ¡½¿±Ù½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÃøÈä±Ù½Å°æ
  • Lateral thoracic artery
    °¡Âʰ¡½¿µ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃøÈ䵿¸Æ
  • Lateral thoracic vein
    °¡Âʰ¡½¿Á¤¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃøÈäÁ¤¸Æ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lateral pterygoid muscle
    ¿ÜÃøÀ͵¹±Ù
  • lateral recess syndrome
    ¿ÜÃøÇÔ¿äÁõÈıº
  • lateral rectus muscle
    ¿ÜÁ÷±Ù
  • lateral resolution
    Ãø¹æÇâ ÇØ»ó·Â
  • lateral sacrococcygeal ligament
    ¿Ü̵̿¹ÌÀδë
  • lateral semicircular canal
    ¿ÜÃø°ñ¹Ý±Ô°ü, ¿ÜÃø¹Ý±Ô°ü
  • lateral shadow
    ¿ÜÃø±×¸²ÀÚ
  • lateral thoracic artery
    ¿ÜÃøÈ䵿¸Æ
  • lateral tubercle
    ¿ÜÃø°áÀý
  • lateral ventricle
    Ãø³ú½Ç
  • lateral wall echo
    Ãøº®¿¡ÄÚ
  • prominence of lateral semicircular canal
    ¿ÜÃø¹Ý°í¸®°ñ°üÀ¶±â, ¿ÜÃø¹Ý±Ô°üÀ¶±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LGN lateral geniculate nucleus; lateral glomerulonephritis
LL large lymphocyte; lateral leminiscus; left lateral; left leg; left lower; left lung; lepromatous [in...
LLF Laki-Lorand factor; left lateral femoral; left lateral flexion
LR labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l...
LRS lactated Ringer solution; lateral recess stenosis; lateral recess syndrome; low rate of stimulation;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NS Nodular Sclerosis
PSS Progressive Systemic Sclerosis
SS Systemic Sclerosis
SSC Systemic Sclerosis
SSc; scleroderma Systemic Sclerosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • spastic spinal paralysis
    °æ¼º ôÃß ¸¶ºñ
    ô¼öÀÇ Ãßü·Î°¡ ¾çÂÊ¿¡¼­ Àå¾Ö¸¦ ¹Þ¾Æ ¾çÂÊ ´Ù¸® ¶Ç´Â ¾çÂÊ ÆÈ´Ù¸®¿¡ ¿îµ¿ ¸¶ºñ°¡ ÀϾ´Â º´. ´Ù¸®ÀÇ ±ÙÀ°ÀÌ ´ç±â°í °Ç¹Ý»ç°¡ Ç×ÁøµÈ´Ù. ÇÑ °¡Áö ÁúȯÀÌ ¾Æ´Ï¶ó ´Ù¹ß¼º °æÈ­Áõ, ¿¬ÇÕ¼º »èº¯¼ºÁõ, ô¼ö Á¾¾ç, º¯Çü¼º °æÃßÁõ, ±Ù À§Ã༺ Ãø»è °æÈ­Áõ µîÀÇ °æ°ú Áß¿¡ ³ªÅ¸³ª´Â ÇÑ Áõ¼¼¶ó°í º¸´Â °ßÇØ°¡ ¸¹´Ù. °æ¼º ô¼ö ¸¶ºñ °¡¿îµ¥ °¡Àå ¸¹Àº °ÍÀº °¡Á·¼º °æ¼º ´ë¸¶ºñ¿Í ¸Åµ¶¿¡ ÀÇÇÑ Ã´¼ö¼º ´ë¸¶ºñÀÌ´Ù. ÀüÀڴ ô¼ö ¼Ò³ú º¯¼ºÁõÀÇ Çϳª·Î ºñ±³Àû ¸¹´Ù. µ¿ÀÏ °¡Á· ³»¿¡¼­ ÀϾ¸ç, ÁÖ·Î 10¼¼ ÀÌÇÏÀÇ ¾î¸°ÀÌ¿¡ ¹ßº´ÇÑ´Ù. ¾çÂÊ ´Ù¸®°¡ ¶¥±â¾î º¸ÇàÀÌ ´Ê°í ³Ñ¾îÁö±â ½¬¿ì¸ç, °Ç¹Ý»ç°¡ Ç×ÁøÇÑ´Ù. ±×·¯³ª Áö°¢À̳ª ¹æ±¤ÀÇ Àå¾Ö´Â ¾ø°í, »óü¿¡µµ Áõ»óÀÌ ³ªÅ¸³ªÁö ¾ÊÀ¸¸ç ±× ÀÌ»óÀÇ ÁøÀüÀº ¾ø´Ù. Ä¡·á´Â Ưº°ÇÑ ¹æ¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ È¿°úÀûÀÌ´Ù. ÈÄÀÚÀÇ °æ¿ì´Â óÀ½¿¡ °£Ç漺 ÆÄÇàÀ¸·Î ÀÚÁÖ ½¬Áö ¾ÊÀ¸¸é °ÉÀ» ¼ö ¾ø´Â »óŰ¡ µÈ´Ù. Ç÷¾×À̳ª ¼ö¾×¿¡µµ º¯È­°¡ ÀϾ´Â °ÍÀ¸·Î Áø´ÜµÈ´Ù. Ä¡·á´Â Æä´Ï½Ç¸°ÀÌ È¿°úÀûÀÌ´Ù.
  • spinal
    ô¼öÀÇ, ôÃßÀÇ
  • spinal accessory cranial nerve
    ºÎ½Å°æ
    ½Â¸ð±Ù, Èä¼âÀ¯µ¹±Ù, ±×¸®°í Àεθ¦ Áö¹èÇÏ´Â ¿îµ¿ µÎ°³ ½Å°æ
  • spinal accessory nerve
    ôÃß ºÎ½Å°æ
  • spinal animal
    ô¼ö µ¿¹°
    ô¼ö°¡ Àý´ÜµÇ¾î ³ú¿ÍÀÇ ¿¬¶ôÀÌ Â÷´ÜµÈ µ¿¹°.
  • spinal apoplexy
    ô¼ö ÃâÇ÷
    ô¼ö ½ÇÁú ³»·ÎÀÇ ÃâÇ÷.
  • spinal branch of posterior intercostal artery
    µÚ ´Á°ñ »çÀÌ µ¿¸Æ ô¼ö °¡Áö, Èĸ¤°£ µ¿¸Æ ô¼ö ºÐÁö
  • spinal canal
    ôÃß °ü
  • spinal column
    ôÁÖ
  • spinal cord anesthesia
    ô¼ö ¸¶Ãë
  • spinal cord gray matter
    ô¼ö ȸ»öÁú
  • spinal cord meningioma
    ô¼ö ¼ö¸·Á¾
  • spinal cord nociceptive projection cell
    ô¼ö À¯ÇØ ¼ö¿ë¼º Åõ»ç ¼¼Æ÷
  • spinal dorsal horn
    ô¼ö ¹èÃø°¢
  • spinal dysraphism
    ôÃß Èıà ¹ÌºÀ, ôÃß Èıà ¹ÌºÀÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
sclerosis corii <dermatology> Hardening of skin.
(04 Mar 1998)
sclerosis cutanea Synonym: scleroderma.
(05 Mar 2000)
sclerosis, multiple The National Multiple Sclerosis Society says of ms that it is a disease that randomly attacks your central nervous system, wearing away the control you have over your body. Symptoms may range from numbness to paralysis and blindness. The progress, severity and specific symptoms cannot be foreseen. You never know when attacks will occur, how long they will last, or how severe they will be. most people are diagnosed with ms between the ages of 20 and 40. In medical terms, ms involves demyelinization of the white matter sometimes extending into the gray matter. Demyelinization is loss of myelin, the coating of nerve fibres composed of lipids (fats) and protein that serves as insulation and permits efficient nerve fibre conduction. The white matter is the part of the brain which contains myelinated nerve fibres and appears white, whereas the gray matter is the cortex of the brain which contains nerve cell bodies and appears gray. When myelin is damaged in ms, nerve fibre conduction is faulty or absent. Impaired bodily functions or altered sensations associated with those demyelinated nerve fibres give rise to the symptoms of ms. Recent research (1998) has also identified nerve cell death as part of the nervous system injury in ms.
(12 Dec 1998)
sclerosis of white matter <radiology> Type of dysmyelinating disease, hereditary, peripheral nervous system unaffected in some disorders Specific diseases: adrenoleukodystrophy, metachromatic leukodystrophy, spongy degeneration (Canavan), globoid cell (Krabbe) leukodystrophy, Alexander disease, Pelizaeus-Merzbacher disease, Cockayne syndrome
(12 Dec 1998)
hippocampal sclerosis A loss of cortical neurons and a reactive astrocytosis in the hippocampal regions of some persons with epilepsy.
(05 Mar 2000)
skin lesions of tuberous sclerosis <radiology> Adenoma sebaceum, Shagreen patches, periungual fibromata, ash-leaf hypopigmentation
(12 Dec 1998)
nodular sclerosis <cardiology, pathology> The progressive narrowing and hardening of the arteries over time.
This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
nuclear sclerosis Increased refractivity of the central portion of the lens of the eye.
See: nuclear cataract.
(05 Mar 2000)
systemic sclerosis <rheumatology> A multisystem disorder of unknown aetiology. It is characterised by fibrosis (scarring) of the skin, blood vessels and internal organs. Involvement of the gastrointestinal tract, heart, kidneys and lungs is common.
(09 Jan 1998)
diffuse infantile familial sclerosis <radiology> Dysmyelinating disease, autosomal recessive, usually presents by 1 yr, specific enzyme deficiency identified, rapid spontaneous nystagmus, poikilothermia
Synonym: Krabbe leukodystrophy
(12 Dec 1998)
disseminated sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
idiopathic hypercalcaemic sclerosis of infants See: idiopathic hypercalcaemia of infants.
(05 Mar 2000)
insular sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
ovulational sclerosis A slowly progressive sclerosis in the walls of the ovarian arteries which commences after puberty.
Synonym: menstrual sclerosis, ovulational sclerosis.
(05 Mar 2000)
endocardial sclerosis <radiology> Unknown aetiology, diffuse thickening of endocardium, few live more than 2 yrs, limited to left chambers in 80%, causes restrictive cardiomyopathy
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á